SCHEMBL6981560

SCHEMBL6981560

CCCCCCCCOC(=O)c1ccc(CCC(=O)N2CCCc3cc(N(CC(=O)OCC)c4ccccc4)ccc32)c(C(=N)N)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
MAPT P10636 3/20 0.34
NOTUM Q6P988 1/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ADRB2 P07550 2/20 0.33
ADRB1 P08588 2/20 0.33
ADRB3 P13945 2/20 0.33
PARP1 P09874 1/20 0.33
TSHR P16473 1/20 0.33
LMNA P02545 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
THRB P10828 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
CNR2 P34972 1/20 0.33
AVPR2 P30518 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980895 0.91 PDK1 (0.40) PDK1PDK2PDK3PDK4MAPT
SCHEMBL6984846 0.90 USP2 (0.38) PDK1PDK2PDK3PDK4MAPT
SCHEMBL7960545 0.84 F2 (0.44) PDK1PDK2PDK3PDK4MAPT
SCHEMBL6984189 0.83 F2 (0.39) PDK1PDK2PDK3PDK4MAPT
SCHEMBL6984052 0.81 ADRB2 (0.48) MAPTTP53SMN1; SMN2ADRB2ADRB1
SCHEMBL6979175 0.80 USP2 (0.39) PDK1PDK2PDK3PDK4TSHR
SCHEMBL6978636 0.79 PDK1 (0.36) PDK1PDK2PDK3PDK4MAPT
SCHEMBL6978188 0.74 LMNA (0.54) MAPTTP53SMN1; SMN2ADRB2ADRB1
Hydrochloric Acid SCHEMBL6977886 0.72 F2 (0.51) PDK1PDK2PDK3PDK4NOTUM
SCHEMBL6984844 0.72 USP2 (0.39) PDK1PDK2PDK3PDK4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed